(Q37108610)

18 August 2017

Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets (English)

1 reference

18 August 2017

1 reference

Joel Mossong

15

0 references

Richard Pebody

object named as

Richard G Pebody

9

0 references

Nick Andrews

3

object named as

Nick Andrews

1 reference

18 August 2017

21

Elizabeth Miller

1 reference

18 August 2017

Anthony Nardone

1

1 reference

18 August 2017

Annedore Tischer

2

1 reference

18 August 2017

Jo Backhouse

4

1 reference

18 August 2017

Heidi Theeten

5

1 reference

18 August 2017

Nina Gatcheva

6

1 reference

18 August 2017

Marios Zarvou

7

1 reference

18 August 2017

Bohumir Kriz

8

1 reference

18 August 2017

Kalman Bartha

10

1 reference

18 August 2017

Darina O'Flanagan

11

1 reference

18 August 2017

Dani Cohen

12

1 reference

18 August 2017

Arnis Duks

13

1 reference

18 August 2017

Algirdas Griskevicius

14

1 reference

18 August 2017

Christopher Barbara

16

1 reference

18 August 2017

Adrianna Pistol

17

1 reference

18 August 2017

Margareta Slaciková

18

1 reference

18 August 2017

Katarina Prosenc

19

1 reference

18 August 2017

Kari Johansen

20

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

8

1 reference

Bulletin of the World Health Organization

inferred from page(s)

published in

1 reference

18 August 2017

86

1 reference

18 August 2017

2

1 reference

18 August 2017

118-125

1 reference

Towards elimination: measles susceptibility in Australia and 17 European countries

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Measles and rubella in the World Health Organization European region: diversity creates challenges

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Vaccination against rubella and measles: quantitative investigations of different policies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Rubella immunity. Defining the level of protective antibody

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979-1992.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Rubella outbreak in an unvaccinated religious community in the Netherlands leads to cases of congenital rubella syndrome.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

A large rubella outbreak, Romania--2003.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Interruption of rubella virus transmission in Australia may require vaccination of adult males: evidence from a Victorian sero-survey.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

New Horizons in the Control of Rubella and Prevention of Congenital Rubella Syndrome in the Americas

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

The European Sero-Epidemiology Network.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Modelling rubella in Europe.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

The re-emergence in 1997 of rubella infections during pregnancy. 11 cases in Clermont-Ferrand

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Preventing congenital rubella infection in the European Region of WHO: 2010 target

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Model selection methodology for inter-laboratory standardisation of antibody titres

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647372

Selective immunization: protection of the individual

4 December 2018

1 reference

12 December 2020

The seroepidemiology of rubella in western Europe

1 reference

12 December 2020

Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland

1 reference

12 December 2020

The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies

1 reference

12 December 2020

Identifiers

DOI

10.2471/BLT.07.042010

1 reference

18 August 2017

1 reference

18 August 2017

1 reference